JD Supra

USPTO Launches Streamlined Claim Set Pilot to Accelerate Patent Examination

The U.S. Patent and Trademark Office (USPTO) introduced a new pilot program offering expedited examination for ...
National Law Review

Federal Circuit Denies Challenges to USPTO Director’s Discretionary Denial Decisions

The Federal Circuit upheld the USPTO director’s discretion to deny IPRs, rejecting due process and APA challenges to the agency’s evolving policy framework.
JD Supra

Claim Slimly, Move Swiftly: USPTO Launches Streamlined Claim Set Pilot

The United States Patent and Trademark Office (USPTO) is launching the Streamlined Claim Set Pilot Program (the pilot program) to evaluate ...
National Law Review

USPTO Launches Streamlined Patent Application Program

For applicants with a patent application having, or amended to have, a streamlined claim set—one independent claim and a maximum of nine singly dependent claims—the United States Patent and Trademark ...
Washingtonian on MSN

Inside Washington’s Controversial Addiction to Autopens

Can’t talk about it. Can’t live without it. From the White House to Capitol Hill, Washington relies on autopens. How did a ...

Aquestive Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Planned U.S. launch of Anaphylm™ in the first quarter of 2026, if approved by the FDA Advanced Anaphylm regulatory activities in Canada and the ...
Le Lézard

Zetagen Therapeutics to Present Preliminary Results from Phase 2 Clinical Trial Targeting Metastatic Breast Cancer to Bone at the 2025 San Antonio Breast Cancer Symposium

Zetagen Therapeutics, a privately held clinical-stage biopharmaceutical company pioneering first-of-its-kind targeted therapies for both primary and metastatic breast cancer, announced today that its ...